HERMAN MICHAEL R reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp reported that Senior VP and General Counsel Michael R. Herman received a grant of 7,215 shares of restricted stock on March 4, 2026. The award was granted at a price of $0.00 per share as part of his equity compensation.
All 7,215 shares are held as direct ownership after the transaction. According to the terms, the restricted shares vest in four equal installments of 25% each year, beginning on March 4, 2027.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux received a grant of 3,173 restricted stock shares. The Form 4 reports this as an acquisition awarded on March 4, 2026 at a stated price of $0.00 per share.
The award vests over time, with 25% of the restricted stock scheduled to vest each year beginning on March 4, 2027. Following this grant, Devereaux is reported as directly owning 3,173 shares related to this award.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. sold 10,000 shares of common stock in an open-market transaction at an average price of $76.3001 per share. The sale used a weighted average price, with individual trades executed between $76.10 and $76.42. After the sale, he directly holds 272,133 common shares, in addition to several indirect holdings through trusts, a family-controlled corporation, and general partnerships.
REG submitted Form 144 notices reporting proposed sales of up to 10,000 common shares. The filing lists vested restricted shares of 9,175 shares vested 02/04/2026 (services rendered) and 825 shares vested 03/06/2015 (services rendered).
Regency Centers, L.P. is offering $450,000,000 of 4.50% Notes due March 15, 2033, with interest payable semi-annually on March 15 and September 15, beginning September 15, 2026. The notes are guaranteed by Regency Centers Corporation and were priced at 99.376% of par.
The issuer expects net proceeds of approximately $443.3 million, which will be used to reduce borrowings under its line of credit, repay the $100 million aggregate principal amount of the 2026 Notes at maturity and for general corporate purposes. Delivery is expected on or about February 23, 2026.
Regency Centers Corporation entered into a new Equity Distribution Agreement and forward master confirmation with RBC Capital Markets and Royal Bank of Canada, adding them as a sales agent, forward seller and forward purchaser under its existing at-the-market equity program for common stock. The combined Equity Distribution Agreements permit offers and sales of shares of common stock from time to time having an aggregate offering price of up to $500,000,000. The structure allows Regency Centers to sell shares directly through sales agents or indirectly via forward sale agreements, with sales agents and forward sellers earning commissions of up to 2.0% of the gross sales price. Regency expects to primarily physically settle forward sales to receive cash proceeds later, but it may also choose cash or net share settlement, which could require delivering cash or shares to the forward purchasers.
Regency Centers Corporation is registering the offer and sale of up to $500,000,000 of its common stock through an ongoing at‑the‑market equity distribution program. The stock may be sold from time to time via multiple sales agents and through forward sale agreements with several major banks.
The company can issue shares directly or have forward purchasers borrow and sell shares as forward sellers, with total sales under the program capped at an aggregate sales price of $500,000,000. Net proceeds from direct issuances and physical settlement of forward sale agreements are intended to fund development and redevelopment projects, potential acquisitions, repayment of revolving credit facility borrowings and other debt, and general corporate purposes.
Regency notes that forward sale agreements may be physically, cash or net share settled, which can create dilution to earnings per share and return on equity or result in cash obligations. The filing also highlights REIT‑specific tax risks if significant gains from cash‑settled forwards were to affect REIT income tests, as well as broader dilution and stock‑price pressure risks from issuing additional common stock.
A security holder filed a Form 144/A notice to potentially sell 15,000 shares of common stock, with an aggregate market value of $1,135,800. The proposed sale, through Charles Schwab Corp on NASDAQ, is targeted for around 02/09/2026.
These 15,000 shares were acquired on 02/10/2023 directly from the issuer as equity compensation, rather than a cash purchase. Shares outstanding were reported at 182,900,978; this is a baseline figure, not the planned sale amount. No sales over the past three months are listed for this holder.
Regency Centers Corp officer Devereaux Terah L, the Principal Accounting Officer, reported several equity-related transactions on February 12, 2026. The filing shows the exercise or conversion of derivative awards into 3,506 shares of Common Stock, partly linked to restricted stock vesting and dividend equivalents.
The report also shows a tax-withholding disposition of 1,479 shares of Common Stock at $73.40 to cover obligations tied to these awards. After these transactions, Devereaux Terah L directly owned 19,230 shares of Common Stock and 8,051 shares of Restricted Stock.
Regency Centers Corporation Senior VP and General Counsel Michael R. Herman reported equity award activity on February 12, 2026. He acquired 7,459 shares of common stock through the vesting and conversion of restricted stock and related dividend equivalents.
To cover tax obligations, 2,807 common shares were disposed of at $73.40 per share, leaving him with 21,601 common shares held directly and 4,257 shares of restricted stock. The company notes that a prior report understated his restricted stock grant by 538 shares, now correctly reflected as of February 17, 2026.